Symmetry Medical (SMA) Misses Q3 EPS by 1c; Guides Lower
More News related to SMA
- Wells Fargo Upgrades Symmetry Medical (SMA) to Market Perform; Cycle Has Bottomed
- Symmetry Medical to Present at 21st Annual Piper Jaffray Health Care Conference
- Symmetry Medical (SMA) Misses Q3 EPS by 1c; Guides Lower
- Symmetry Medical Reports Third Quarter 2009 Financial Results
- Trading Radar for 11/05: Starbucks (SBUX), CBS Corp. (CBS), CVS (CVS), Toyota (TM), Thomson Reuters (TRI)
Symmetry Medical, Inc. (NYSE: SMA) reports Q3 EPS of $0.15, 1 cents below the analyst estimate of $0.16. Revenue for the quarter was $87.2 million, which compares to the estimate of $91.94 million.
Based on current order flow and anticipated customer demand for the remainder of the 2009, Symmetry is adjusting its previously stated annual revenue guidance to a range of $355 million to $365 million, from $385 million to $405 million. The Company now expects full year 2009 earnings per share to be in the range of $0.63 to $0.68 per diluted share, from $0.77 to $0.85.
Related Categories
EarningsGuidance
Hot List
Stocks Mentioned
+0.16Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
